Edition:
India

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

22.47USD
12:06am IST
Change (% chg)

$0.21 (+0.94%)
Prev Close
$22.26
Open
$22.20
Day's High
$22.63
Day's Low
$21.89
Volume
118,251
Avg. Vol
235,118
52-wk High
$22.82
52-wk Low
$8.64

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.63
Market Cap(Mil.): $1,451.04
Shares Outstanding(Mil.): 65.19
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates